STOCK TITAN

SeaSpine to Host Analyst & Investor Event on September 30, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

SeaSpine Holdings Corporation (NASDAQ: SPNE) announced an Analyst & Investor Event in Boston on September 30, 2021, from 7:30 a.m. to 8:45 a.m. ET. The event will feature remarks from the leadership team discussing the company’s innovative technologies and growth strategies. A live webcast, including a slide presentation, will be available on their website, with an archived replay following the event. SeaSpine specializes in surgical solutions for spinal disorders, offering a wide range of orthobiologics and spinal implants to support various surgical procedures.

Positive
  • None.
Negative
  • None.

CARLSBAD, Calif., Sept. 16, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will host an Analyst & Investor Event in Boston, Massachusetts on Thursday, September 30 from 7:30 a.m. to 8:45 a.m. Eastern Time.

The meeting will include remarks from members of the SeaSpine leadership team on the Company’s differentiated technologies and growth strategy.

A live webcast, including slide presentation, will be available on the SeaSpine website at www.investor.seaspine.com. An archived replay will also be available on the Company’s website following the meeting.

About SeaSpine
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions, as well as a market leading surgical navigation system, to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic, and cervical spine. SeaSpine’s orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine’s spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in orthobiologic sciences, as well as spinal implants, software and advanced optics product development, allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide through a committed network of increasingly exclusive distribution partners.

Investor Relations Contact
Leigh Salvo
(415) 937-5402
ir@seaspine.com 


FAQ

What is the date and time of the SeaSpine Analyst & Investor Event?

The SeaSpine Analyst & Investor Event is scheduled for September 30, 2021, from 7:30 a.m. to 8:45 a.m. Eastern Time.

Where will the SeaSpine Analyst & Investor Event take place?

The event will take place in Boston, Massachusetts.

How can I watch the SeaSpine Analyst & Investor Event?

You can watch the event live on SeaSpine's website, and an archived replay will be available afterward.

What topics will be discussed at the SeaSpine Analyst & Investor Event?

The SeaSpine leadership team will discuss the company’s differentiated technologies and growth strategy during the event.

What is SeaSpine's focus in the medical technology sector?

SeaSpine focuses on surgical solutions for spinal disorders, including orthobiologics and spinal implants.

SPNE

NASDAQ:SPNE

SPNE Rankings

SPNE Latest News

SPNE Stock Data

360.18M
33.85M
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Carlsbad